News

Practical recommendations for erenumab (Aimovig) – 2020 update

Erenumab (Aimovig®) was the first monoclonal antibody approved for migraine prevention in Germany in November 2018. This allowed for more than a year of experience to be gained with the practical use of this innovative substance in everyday clinical practice [...]

Migraine (m/f/d)

Generations of students have struggled with the problem that a word can have different genders in different languages. The assignment to feminine, masculine, or neuter often seems rather arbitrary. A typical [...]

Can diet actually be used as a therapy for migraines?

New research suggests that migraine is an energy-deficit syndrome of the brain involving dysregulation of energy metabolism in the mitochondria of nerve cells. This leads to a cascade of neurological symptoms. Numerous substances have been identified using magnetic resonance spectroscopy (MRS) [...]

Migraine and headache prevention at the university

In Germany, about two-thirds of students suffer from headaches. It's high time something changed! The initiators of the action day against migraines and headaches at the Dresden University of Technology (from left to right): Dr. Astrid [...]

Cluster headache: Public patient information day on September 21, 2019 postponed

Important change: The planned public patient day on September 21, 2019, has to be postponed due to current circumstances. A new date will be announced. ----------------------------------------------- Our joint patient information day of the Kiel Pain Clinic and the Federal Association of Cluster Headache Self-Help Groups (CSG) [...]

Doctors should be able to prescribe apps

Berlin, July 10, 2019. Cabinet approves draft Digital Healthcare Act – Federal Health Minister Jens Spahn: “Digital healthcare is patient-friendly.” Apps on prescription, interesting offers for online consultations, and the possibility of accessing the secure data network throughout treatment [...]